Lopinavir and Ritonavir
NDC 33342-164 · Macleods Pharmaceuticals Limited
Generic nameLopinavir and Ritonavir
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LOPINAVIR, RITONAVIR
Strength200; 50 mg/1; mg/1
Pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
Marketing categoryANDA
Packages
33342-164-09 — 60 TABLET, FILM COATED in 1 BOTTLE (33342-164-09)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0074-2340 — Ritonavir, 0074-3008 — Lopinavir and Ritonavir, 0074-3399 — Ritonavir, 0074-3956 — Lopinavir and Ritonavir, 0074-4014 — Lopinavir and Ritonavir, 31722-556 — Lopinavir and ritonavir, 31722-597 — Ritonavir, 31722-603 — Lopinavir and ritonavir, 33342-163 — Lopinavir and Ritonavir, 42385-933 — Lopinavir and Ritonavir, 42385-934 — Lopinavir and Ritonavir, 60687-420 — Ritonavir, 63629-5702 — Ritonavir, 65162-061 — Ritonavir, 65862-687 — Ritonavir, 68071-3898 — Ritonavir, 69097-655 — ritonavir 100 mg, 71335-2610 — Ritonavir